499 Shares in Elevance Health, Inc. (NYSE:ELV) Acquired by BSW Wealth Partners

BSW Wealth Partners acquired a new stake in Elevance Health, Inc. (NYSE:ELV) during the third quarter, according to its most recent filing with the SEC. The firm acquired 499 shares of the company’s stock, valued at approximately $259,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank & Trust Co bought a new stake in Elevance Health during the 2nd quarter worth about $27,000. PSI Advisors LLC acquired a new position in shares of Elevance Health in the 3rd quarter valued at $27,000. Opal Wealth Advisors LLC bought a new stake in Elevance Health in the second quarter valued at about $28,000. Strategic Financial Concepts LLC bought a new position in Elevance Health during the second quarter worth about $30,000. Finally, Eastern Bank acquired a new position in shares of Elevance Health during the 3rd quarter worth about $31,000. 89.24% of the stock is owned by institutional investors and hedge funds.

Elevance Health Trading Up 2.0 %

NYSE ELV opened at $414.01 on Monday. Elevance Health, Inc. has a 12 month low of $397.98 and a 12 month high of $567.26. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The stock has a 50 day moving average of $501.96 and a 200-day moving average of $521.52. The company has a market cap of $96.02 billion, a PE ratio of 15.09, a PEG ratio of 1.21 and a beta of 0.85.

Elevance Health (NYSE:ELV) last announced its quarterly earnings results on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing analysts’ consensus estimates of $9.66 by ($1.29). The firm had revenue of $44.72 billion during the quarter, compared to analyst estimates of $43.47 billion. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $8.99 EPS. On average, equities research analysts anticipate that Elevance Health, Inc. will post 32.93 EPS for the current fiscal year.

Elevance Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Thursday, December 5th will be given a $1.63 dividend. The ex-dividend date of this dividend is Thursday, December 5th. This represents a $6.52 dividend on an annualized basis and a dividend yield of 1.57%. Elevance Health’s payout ratio is 23.77%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Bank of America reissued a “neutral” rating and set a $530.00 price target (down from $646.00) on shares of Elevance Health in a research report on Thursday, July 18th. TD Cowen decreased their target price on Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a research note on Monday, October 21st. Argus cut Elevance Health from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Cantor Fitzgerald cut their price target on shares of Elevance Health from $600.00 to $485.00 and set an “overweight” rating on the stock in a research note on Friday, October 18th. Finally, Barclays lowered their price objective on shares of Elevance Health from $622.00 to $501.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $551.07.

Insider Transactions at Elevance Health

In related news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the stock in a transaction on Friday, October 18th. The stock was sold at an average price of $432.14, for a total value of $3,205,182.38. Following the sale, the executive vice president now owns 8,423 shares in the company, valued at approximately $3,639,915.22. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.35% of the stock is currently owned by corporate insiders.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.